| J9271 | Injection, pembrolizumab, 1 mg | 28,200 | $40 | $1.2M |
| J0897 | Injection, denosumab, 1 mg | 20,880 | $20 | $375.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,930 | $30 | $201.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,180 | $100 | $114K |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 3,960 | $30 | $103K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 12,630 | $10 | $75.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 62,250 | $1 | $62.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 630 | $100 | $60.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 610 | $60 | $38.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 230 | $140 | $30.6K |